News & Updates

Show Multimedia Only

Lower BMD tied to endothelial dysfunction in RA

23 Apr 2025 by

Patients with rheumatoid arthritis (RA) who have lower bone mineral density (BMD) are more likely to experience endothelial dysfunction but not aortic stiffness, suggests a Singapore study.

Lower BMD tied to endothelial dysfunction in RA

23 Apr 2025

Anti–IFN-α receptor mAb treatment for an SLE patient previously treated with rituximab and belimumab

22 Apr 2025 by

A 24-year-old clerk and mother of two presented to our hospital in August 2010 with fever, malar rash on the face, vasculitic rash on the fingers and alopecia. Her medical and family histories were unremarkable.

Anti–IFN-α receptor mAb treatment for an SLE patient previously treated with rituximab and belimumab

22 Apr 2025

Does inflammaging worsen Rh-irAEs after ICI treatment?

18 Apr 2025

Inflammaging plays no significant role in rheumatic immune-related adverse events (Rh-irAEs), as shown by the comparable numbers of overall irAEs and the severity of RH-irAEs between older and younger patients who developed these conditions after treatment with immune checkpoint inhibitors (ICIs), a study has shown.

Does inflammaging worsen Rh-irAEs after ICI treatment?

18 Apr 2025

Diabetic ulcer ups PAH risk in SSc patients

17 Apr 2025

Patients with systemic sclerosis (SSc) who have diabetic ulcer (DU) are at an increased risk for developing pulmonary arterial hypertension (PAH), reports a study. However, the use of bosentan for preventing DU may reduce such risk.

Diabetic ulcer ups PAH risk in SSc patients

17 Apr 2025

Yoga noninferior to strengthening exercises for managing knee OA

17 Apr 2025

In patients with knee osteoarthritis (OA), yoga is only as good as strengthening exercises at reducing pain, according to a study.

Yoga noninferior to strengthening exercises for managing knee OA

17 Apr 2025

Gradual adalimumab tapering minimizes uveitis recurrence in children

15 Apr 2025

In children with noninfectious uveitis being treated with adalimumab, tapering speed appears to affect the risk of relapse, with a slow, gradual approach emerging as the optimal strategy, according to a multicentre retrospective cohort study.

Gradual adalimumab tapering minimizes uveitis recurrence in children

15 Apr 2025

Hepatitis A vaccine may be safely administered to children on biologic therapy

11 Apr 2025

Paediatric patients with autoinflammatory diseases undergoing treatment with canakinumab and tocilizumab can be safely vaccinated against hepatitis A, according to a prospective interventional study.

Hepatitis A vaccine may be safely administered to children on biologic therapy

11 Apr 2025

Original New Drug Application Approvals by US FDA (16-31 March 2025)

10 Apr 2025

New drug applications approved by US FDA as of 16-31 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2025)

10 Apr 2025

Original New Drug Application Approvals by US FDA (1-15 March 2025)

04 Apr 2025

New drug applications approved by US FDA as of 1-15 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 March 2025)

04 Apr 2025

Sjögren disease patients at increased risk of death

25 Mar 2025

Patients with Sjögren disease (SD) are at heightened risk of mortality from infections, malignancies, and cardiovascular disease (CVD), reveals a study.

Sjögren disease patients at increased risk of death

25 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Lower BMD tied to endothelial dysfunction in RA

Lower BMD tied to endothelial dysfunction in RA

Anti–IFN-α receptor mAb treatment for an SLE patient previously treated with rituximab and belimumab

Anti–IFN-α receptor mAb treatment for an SLE patient previously treated with rituximab and belimumab

Does inflammaging worsen Rh-irAEs after ICI treatment?

Does inflammaging worsen Rh-irAEs after ICI treatment?

Diabetic ulcer ups PAH risk in SSc patients

Diabetic ulcer ups PAH risk in SSc patients

Yoga noninferior to strengthening exercises for managing knee OA

Yoga noninferior to strengthening exercises for managing knee OA

Gradual adalimumab tapering minimizes uveitis recurrence in children

Gradual adalimumab tapering minimizes uveitis recurrence in children

Hepatitis A vaccine may be safely administered to children on biologic therapy

Hepatitis A vaccine may be safely administered to children on biologic therapy

Original New Drug Application Approvals by US FDA (16-31 March 2025)

Original New Drug Application Approvals by US FDA (16-31 March 2025)

Original New Drug Application Approvals by US FDA (1-15 March 2025)

Original New Drug Application Approvals by US FDA (1-15 March 2025)

Sjögren disease patients at increased risk of death

Sjögren disease patients at increased risk of death